Citadel Advisors’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.78M | Buy |
1,765,481
+372,143
| +27% | +$796K | ﹤0.01% | 2160 |
|
|
2025
Q1 | $1.6M | Sell |
1,393,338
-3,088,129
| -69% | -$3.55M | ﹤0.01% | 2800 |
|
|
2024
Q4 | $9.81M | Buy |
4,481,467
+26,457
| +0.6% | +$57.9K | ﹤0.01% | 1335 |
|
|
2024
Q3 | $9.71M | Sell |
4,455,010
-1,303,384
| -23% | -$2.84M | ﹤0.01% | 1283 |
|
|
2024
Q2 | $13.3M | Sell |
5,758,394
-132,498
| -2% | -$306K | ﹤0.01% | 1072 |
|
|
2024
Q1 | $31.8M | Buy |
5,890,892
+1,624,939
| +38% | +$8.77M | 0.01% | 667 |
|
|
2023
Q4 | $10.5M | Buy |
4,265,953
+1,326,472
| +45% | +$3.28M | ﹤0.01% | 1189 |
|
|
2023
Q3 | $102M | Buy |
2,939,481
+152,349
| +5% | +$5.29M | 0.02% | 224 |
|
|
2023
Q2 | $91.4M | Sell |
2,787,132
-226,891
| -8% | -$7.44M | 0.02% | 258 |
|
|
2023
Q1 | $101M | Sell |
3,014,023
-753,320
| -20% | -$25.2M | 0.02% | 214 |
|
|
2022
Q4 | $124M | Buy |
3,767,343
+296,179
| +9% | +$9.71M | 0.03% | 162 |
|
|
2022
Q3 | $121M | Sell |
3,471,164
-420,164
| -11% | -$14.7M | 0.03% | 132 |
|
|
2022
Q2 | $47.6M | Sell |
3,891,328
-20,582
| -0.5% | -$252K | 0.01% | 395 |
|
|
2022
Q1 | $51.4M | Buy |
3,911,910
+20,882
| +0.5% | +$274K | 0.01% | 429 |
|
|
2021
Q4 | $74.7M | Buy |
+3,891,028
| New | +$74.7M | 0.02% | 311 |
|